Cargando…
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers
BACKGROUND: Human endogenous retroviruses (HERVs) comprise approximately 8% of the human genome and while the majority are transcriptionally silent, the most recently integrated HERV, HERV-K (HML-2), remains active. During HIV infection, HERV-K (HML-2) specific mRNA transcripts and viral proteins ca...
Autores principales: | de Mulder, Miguel, SenGupta, Devi, Deeks, Steven G., Martin, Jeffrey N., Pilcher, Christopher D., Hecht, Frederick M., Sacha, Jonah B., Nixon, Douglas F., Michaud, Henri-Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568399/ https://www.ncbi.nlm.nih.gov/pubmed/28830571 http://dx.doi.org/10.1186/s12977-017-0365-2 |
Ejemplares similares
-
Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection
por: Michaud, Henri-Alexandre, et al.
Publicado: (2014) -
Ancient Adversary – HERV-K (HML-2) in Cancer
por: Dervan, Eoin, et al.
Publicado: (2021) -
HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease
por: Hohn, Oliver, et al.
Publicado: (2013) -
Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins
por: Mayer, Jens, et al.
Publicado: (2018) -
Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome
por: Jia, Lei, et al.
Publicado: (2022)